DCA Effects in ALS Models 48. Dupuis L, Loeffler JP (2009) Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol 9: 341–346. 49. Wilson JS, Rushing G, Johnson BL, Kline JA, Back MR, et al. (2003) Dichloroacetate increases skeletal muscle pyruvate dehydrogenase activity during acute limb ischemia. Vasc Endovascular Surg 37: 191–195. 50. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772–1775. 51. Vargas MR (2005) Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes: Consequences for motor neuron survival. Journal of Biological Chemistry 280: 25571–25579. 52. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, et al. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant- mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 99: 1604–1609. 53. Cassina P, Peluffo H, Pehar M, Martinez-Palma L, Ressia As, et al. (2002) Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. Journal of Neuroscience Research 67: 21–29. 54. Gnaiger E (2007) Mitochondrial Pathways and Respiratory Control. ORO- BOROS MiPNet Publications, Innsbruck. 96 p. PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e34776